CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
70 hedge funds and large institutions have $338M invested in Crescent Biopharma, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 14 closing their positions.
Holders
70
Holders Change
+26
Holders Change %
+59.09%
% of All Funds
1.75%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
40
Increased
15
Reduced
12
Closed
14
Calls
$337K
Puts
$1.12M
Net Calls
-$779K
Net Calls Change
-$779K
Top Buyers
1 |
1
Jennison Associates
New York
|
$17.8M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$16.8M |
3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$15.2M |
4 |
4
Millennium Management
New York
|
$15.4M |
5 |
![]()
5
Franklin Resources
San Mateo,
California
|
$20.7M |